Simona Tomassetti
Rimini, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Clinical Outcomes of Ruxolitinib Treatment in Patients With IPSS Intermediate-1-Risk Myelofibrosis: Interim Analysis From an Italian, Prospective Study (ROMEI).
Journal: Hematological oncology
Published: November 13, 2025
PNH clones prevalence study in ph-negative myeloproliferative neoplasms: a multicenter Italian study.
Journal: Annals of hematology
Published: March 26, 2025
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI).
Journal: Cancer
Published: October 24, 2024
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study.
Journal: HemaSphere
Published: July 31, 2024
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study.
Journal: Cancers
Published: June 21, 2023
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP.
Journal: Blood advances
Published: August 20, 2019
Serum free light-chain assay for the detection and monitoring of multiple myeloma and related conditions.
Journal: Therapeutic advances in hematology
Published: April 24, 2013
Lenalidomide in combination with dexamethasone in elderly patients with advanced, relapsed or refractory multiple myeloma and renal failure.
Journal: Mediterranean journal of hematology and infectious diseases
Published: April 04, 2013
Autologous stem cell transplantation for aggressive lymphomas.
Journal: Mediterranean journal of hematology and infectious diseases
Published: October 22, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026